Difficulty: Medium
Average Score: 84%
Practice
Alveolar type of rhabdomyosarcoma accounts for approximately 1/3 of all cases of pediatric RMS and carries the poorest prognosis. Of the following, the MOST common site of involvement by alveolar type RMS is
Correct answer
C
Rationale
In this question, the correct answer is C) extremities. Alveolar type rhabdomyosarcoma (RMS) is a highly aggressive subtype accounting for about one-third of pediatric RMS cases. The extremities, particularly the muscles of the arms and legs, are the most common sites of involvement for alveolar type RMS. This is due to the nature of this subtype which tends to arise in the soft tissues of the body.
Option A) orbit is less common for alveolar type RMS, as orbital RMS typically presents as embryonal subtype.
Option B) middle ear is associated with embryonal type RMS, not alveolar type.
Option D) bladder involvement is more commonly seen in genitourinary RMS, which can be of both embryonal and alveolar subtypes.
In an educational context, understanding the different subtypes of RMS and their characteristic sites of involvement is crucial for healthcare providers caring for pediatric patients. Recognizing these patterns can aid in early detection, appropriate treatment planning, and prognostic discussions with patients and families. This knowledge is essential for pediatric primary care providers to ensure timely referrals and multidisciplinary management for better outcomes in pediatric oncology cases.
Option A) orbit is less common for alveolar type RMS, as orbital RMS typically presents as embryonal subtype.
Option B) middle ear is associated with embryonal type RMS, not alveolar type.
Option D) bladder involvement is more commonly seen in genitourinary RMS, which can be of both embryonal and alveolar subtypes.
In an educational context, understanding the different subtypes of RMS and their characteristic sites of involvement is crucial for healthcare providers caring for pediatric patients. Recognizing these patterns can aid in early detection, appropriate treatment planning, and prognostic discussions with patients and families. This knowledge is essential for pediatric primary care providers to ensure timely referrals and multidisciplinary management for better outcomes in pediatric oncology cases.